COMMUNICATION
Notice
Total 11
-
11Astrocytic monoamine oxidase B (MAOB)–gamma-aminobutyric acid (GABA) axis as a molecular brake on re
DATE : 2025-09-11
VIEW : 599
-
10Astrocytic gamma-aminobutyric acid dysregulation as a therapeutic target for posttraumatic stress di
DATE : 2025-07-29
VIEW : 599
-
9Hypothalamic GABRA5-positive neurons control obesity via astrocytic GABA
DATE : 2025-06-04
VIEW : 630
-
8Astrocytic MAOB-GABA axis as a molecular brake on repair following spinal cord injury
DATE : 2025-06-04
VIEW : 588
-
7Severe reactive astrocytes precipitate pathological hallmarks of Alzheimer’s disease via H2O2 − prod
DATE : 2025-06-04
VIEW : 707
-
6KDS2010, a Newly Developed Reversible MAO‑B Inhibitor, as an Efective Therapeutic Candidate for Park
DATE : 2025-06-04
VIEW : 682
-
5Excessive Astrocytic GABA Causes Cortical Hypometabolism and Impedes Functional Recovery after Subco
DATE : 2025-06-04
VIEW : 599
-
4Newly developed reversible MAO-B inhibitor circumvents the shortcomings of irreversible inhibitors i
DATE : 2025-06-04
VIEW : 639
-
3GABA from reactive astrocytes impairs memory in mouse models of Alzheimer's disease
DATE : 2025-06-04
VIEW : 689
-
2Neurobiogen exhibit booth at '2024 BIO International Convention'.
DATE : 2024-05-29
VIEW : 1757
- Add(06714) 2 FL, Bangbae BLDG, 9, Myeongdal-ro, Seocho-gu, Seoul, Republic of Korea
- Tel+82-70-4018-8009
- Fax+82-02-3486-2613
- E-mailneuro_reply@neurobiogen.com
FAMILY SITE
COPYRIGHT ⓒ 2025 NEUROBIOGEN. All rights reserved